Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 2,311

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

2020 ESC Guidelines for the management of adult congenital heart disease

Open access
Baumgartner, Helmut, De Backer, Julie, Babu-Narayan, Sonya V, Budts, Werner, Chessa, Massimo, Diller, Gerhard-Paul, lung, Bernard, Kluin, Jolanda, Lang, Irene M, Meijboom, Folkert, Moons, Philip, Mulder, Barbara J M, Oechslin, Erwin, Roos-Hesselink, Jolien W, Schwerzmann, Markus, Sondergaard, Lars, Zeppenfeld, Katja, ESC Scientific Document Group, Ernst, Sabine, Ladouceur, Magalie, Aboyans, Victor, Alexander, David, Christodorescu, Ruxandra, Corrado, Domenico, D'Alto, Michele, de Groot, Natasja, Delgado, Victoria, Di Salvo, Giovanni, Dos Subira, Laura, Eicken, Andreas, Fitzsimons, Donna, Frogoudaki, Alexandra A, Gatzoulis, Michael, Heymans, Stephane, Hörer, Jürgen, Houyel, Lucile, Jondeau, Guillaume, Katus, Hugo A, Landmesser, Ulf, Lewis, Basil S, Lyon, Alexander, Mueller, Christian E, Mylotte, Darren, Petersen, Steffen E, Petronio, Anna Sonia, Roffi, Marco, Rosenhek, Raphael, Shlyakhto, Evgeny, Simpson, Iain A, Sousa-Uva, Miguel, Torp-Pedersen, Christian Tobias, Touyz, Rhian M, Van De Bruaene, Alexander, Babu-Narayan, Sonya V, Budts, Werner, Chessa, Massimo, Diller, Gerhard-Paul, Iung, Bernard, Kluin, Jolanda, Lang, Irene M, Meijboom, Folkert, Moons, Philip, Mulder, Barbara J M, Oechslin, Erwin, Roos-Hesselink, Jolien W, Schwerzmann, Markus, Sondergaard, Lars, Zeppenfeld, Katja, Hammoudi, Naima, Grigoryan, Svetlana V, Mair, Johannes, Imanov, Galib, Chesnov, Jouri, Bondue, Antoine, Nabil, Naser, Kaneva, Anna, Brida, Margarita, Hadjisavva, Ourania, Rubackova-Popelova, Jana, Nielsen, Dorte Guldbrand, El Sayed, Maiy Hamdy, Ermel, Raili, Sinisalo, Juha, Thambo, Jean-Benoit, Bakhutashvili, Zviad, Walther, Claudia, Giannakoulas, George, Bálint, Olga Hajnalka, Lockhart, Christopher J, Murrone, Amiram NirItaly:Adriano, Ahmeti, Artan, Lunegova, Olga, Rudzitis, Ainars, Saliba, Zakhia, Gumbiene, Lina, Wagner, Kerstin, Caruana, Maryanne, Bulatovic, Nebojsa, Amri, Rachida, Bouma, Berto J, Srbinovska-Kostovska, Elizabeta, Estensen, Mette-Elise, Tomkiewicz-Pajak, Lidia, Coman, Ioan Mircea, Moiseeva, Olga, Zavatta, Marco, Stojsic-Milosavljevic, Anastazija, Simkova, Iveta, Prokselj, Katja, Gallego, Pastora, Johansson, Bengt, Greutmann, Matthias, Boughzela, Essia, Sirenko, Yuriy, Coats, Louise·2021·European Heart Journal
DOI 10.1093/eurheartj/ehaa554
Open this paper in CoChat — free account

Abstract

The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication.The ESC is not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies.Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver.Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations.It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehaa554

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Research works printed but not linked: 309

  1. Camm, 2019, The ESC Textbook of Cardiovascular Medicine
  2. Moons, 2010, Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium, Circulation, 122, 2264, 10.1161/CIRCULATIONAHA.110.946343 · DOI · Paper page
  3. Marelli, 2014, Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010, Circulation, 130, 749, 10.1161/CIRCULATIONAHA.113.008396 · DOI · Paper page
  4. Moons, 2010, Group on Grown-up Congenital Heart Disease. Structure and activities of adult congenital heart disease programmes in Europe, Eur Heart J, 31, 1305, 10.1093/eurheartj/ehp551 · DOI
  5. Baumgartner, 2014, Working Group on Grown-up Congenital Heart Disease of the European Society of Cardiology. Recommendations for organization of care for adults with congenital heart disease and for training in the subspecialty of ‘Grown-up Congenital Heart Disease’ in Europe: a position paper of the Working Group on Grown-up Congenital Heart Disease of the European Society of Cardiology, Eur Heart J, 35, 686, 10.1093/eurheartj/eht572 · DOI · Paper page
  6. Deanfield, 2003, Management of grown up congenital heart disease, Eur Heart J, 24, 1035, 10.1016/S0195-668X(03)00131-3 · DOI · Paper page
  7. Moons, 2008, Implementation of transition programs can prevent another lost generation of patients with congenital heart disease, Eur J Cardiovasc Nurs, 7, 259, 10.1016/j.ejcnurse.2008.10.001 · DOI
  8. Thomet, 2019, ESC Working Group on Grown-up Congenital Heart Disease. Staffing, activities, and infrastructure in 96 specialised adult congenital heart disease clinics in Europe, Int J Cardiol, 292, 100, 10.1016/j.ijcard.2019.04.077 · doi:10.1016/j.ijcard.2019.04.077
  9. Kovacs, 2005, Biopsychosocial experiences of adults with congenital heart disease: review of the literature, Am Heart J, 150, 193, 10.1016/j.ahj.2004.08.025 · DOI · Paper page
  10. Moons, 2002, Comprehensive care for adults with congenital heart disease: expanding roles for nurses, Eur J Cardiovasc Nurs, 1, 23, 10.1016/S1474-5151(01)00014-7 · DOI
  11. Gratz, 2009, Self-estimated physical functioning poorly predicts actual exercise capacity in adolescents and adults with congenital heart disease, Eur Heart J, 30, 497, 10.1093/eurheartj/ehn531 · DOI
  12. Uretsky, 2015, Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial, J Am Coll Cardiol, 65, 1078, 10.1016/j.jacc.2014.12.047 · DOI · Paper page
  13. Li, 2018, Consensus recommendations for echocardiography in adults with congenital heart defects from the International Society of Adult Congenital Heart Disease (ISACHD), Int J Cardiol, 272, 77, 10.1016/j.ijcard.2018.07.058 · DOI
  14. Mertens, 2016, Echocardiography in Pediatric and Congenital Heart Disease: From Fetus to Adult
  15. Brignole, 2013, 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA), Eur Heart J, 34, 2281, 10.1093/eurheartj/eht150 · DOI · Paper page
  16. Kilner, 2015, ESC Textbook of Cardiovascular Imaging, 563
  17. Habib, 2015, ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM), Eur Heart J, 36, 3075, 10.1093/eurheartj/ehv319 · DOI · Paper page
  18. Budts, 2013, Physical activity in adolescents and adults with congenital heart defects: individualized exercise prescription, Eur Heart J, 34, 3669, 10.1093/eurheartj/eht433 · DOI · Paper page
  19. Baumgartner, 2017, 2017 ESC/EACTS Guidelines for the management of valvular heart disease, Eur Heart J, 38, 2739, 10.1093/eurheartj/ehx391 · DOI · Paper page
  20. Baggen, 2017, Prognostic value of N-terminal pro-B-type natriuretic peptide, troponin-T, and growth-differentiation factor 15 in adult congenital heart disease, Circulation, 135, 264, 10.1161/CIRCULATIONAHA.116.023255 · DOI
  21. Van De Bruaene, 2018, Phenotype, management and predictors of outcome in a large cohort of adult congenital heart disease patients with heart failure, Int J Cardiol, 252, 80, 10.1016/j.ijcard.2017.10.086 · DOI
  22. Hopkins, 2004, Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion, Circulation, 109, 2872, 10.1161/01.CIR.0000129305.25115.80 · doi:10.1161/01.cir.0000129305.25115.80
  23. Diller, 2015, Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre, Circulation, 132, 2118, 10.1161/CIRCULATIONAHA.115.017202 · DOI · Paper page
  24. Budts, 2016, Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology, Eur Heart J, 37, 1419, 10.1093/eurheartj/ehv741 · DOI · Paper page
  25. Ponikowski, 2016, ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC, Eur Heart J, 37, 2129, 10.1093/eurheartj/ehw128 · DOI · Paper page
  26. Hernandez-Madrid, 2018, Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital Heart Disease, endorsed by HRS, PACES, APHRS, and SOLAECE, Europace, 20, 1719, 10.1093/europace/eux380 · DOI · Paper page
  27. Van De Bruaene, 2018, Management of acute heart failure in adult patients with congenital heart disease, Heart Fail Rev, 23, 1, 10.1007/s10741-017-9664-x · DOI
  28. Zeppenfeld, 2007, Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus, Circulation, 116, 2241, 10.1161/CIRCULATIONAHA.107.723551 · DOI · Paper page
  29. Kapel, 2015, Re-entry using anatomically determined isthmuses: a curable ventricular tachycardia in repaired congenital heart disease, Circ Arrhythm Electrophysiol, 8, 102, 10.1161/CIRCEP.114.001929 · DOI
  30. Janse, 2004, Electrophysiological changes in heart failure and their relationship to arrhythmogenesis, Cardiovasc Res, 61, 208, 10.1016/j.cardiores.2003.11.018 · DOI · Paper page
  31. Kirchhof, 2016, 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, Eur Heart J, 37, 2893, 10.1093/eurheartj/ehw210 · DOI · Paper page
  32. Oechslin, 2000, Mode of death in adults with congenital heart disease, Am J Cardiol, 86, 1111, 10.1016/S0002-9149(00)01169-3 · DOI · Paper page
  33. Priori, 2015, 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), Eur Heart J, 36, 2793, 10.1093/eurheartj/ehv316 · DOI · Paper page
  34. Engelfriet, 2007, Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease, Heart, 93, 682, 10.1136/hrt.2006.098848 · DOI · Paper page
  35. Simonneau, 2019, Haemodynamic definitions and updated clinical classification of pulmonary hypertension, Eur Respir J, 53, 1801913, 10.1183/13993003.01913-2018 · DOI · Paper page
  36. Dimopoulos, 2018, Definition and Management of segmental pulmonary hypertension, J Am Heart Assoc, 7, 10.1161/JAHA.118.008587 · DOI
  37. van Riel, 2014, Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification, Int J Cardiol, 174, 299, 10.1016/j.ijcard.2014.04.072 · DOI
  38. Manes, 2014, Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups, Eur Heart J, 35, 716, 10.1093/eurheartj/eht072 · DOI · Paper page
  39. Vanderpool, 2018, Hematocrit-corrected pulmonary vascular resistance, Am J Respir Crit Care Med, 198, 305, 10.1164/rccm.201801-0081PP · DOI
  40. Diller, 2016, German Competence Network for Congenital Heart Defects Investigators. Current therapy and outcome of Eisenmenger syndrome: data of the German National Register for congenital heart defects, Eur Heart J, 37, 1449, 10.1093/eurheartj/ehv743 · doi:10.1093/eurheartj/ehv743
  41. Dimopoulos, 2010, Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension, Circulation, 121, 20, 10.1161/CIRCULATIONAHA.109.883876 · DOI · Paper page
  42. Rondelet, 2012, Prolonged overcirculation-induced pulmonary arterial hypertension as a cause of right ventricular failure, Eur Heart J, 33, 1017, 10.1093/eurheartj/ehr111 · doi:10.1093/eurheartj/ehr111
  43. Gabriels, 2014, A different view on predictors of pulmonary hypertension in secundum atrial septal defect, Int J Cardiol, 176, 833, 10.1016/j.ijcard.2014.08.009 · DOI
  44. Goetschmann, 2008, Frequency of severe pulmonary hypertension complicating "isolated" atrial septal defect in infancy, Am J Cardiol, 102, 340, 10.1016/j.amjcard.2008.03.061 · doi:10.1016/j.amjcard.2008.03.061
  45. Akagi, 2018, Treat-and-repair strategy is a feasible therapeutic choice in adult patients with severe pulmonary arterial hypertension associated with a ventricular septal defect: case series, Eur Heart J Case Rep, 2, 1
  46. Bush, 1988, Correlations of lung morphology, pulmonary vascular resistance, and outcome in children with congenital heart disease, Br Heart J, 59, 480, 10.1136/hrt.59.4.480 · doi:10.1136/hrt.59.4.480
  47. Kannan, 2003, K. Long-term outcome of patients operated for large ventricular septal defects with increased pulmonary vascular resistance, Indian Heart J, 55, 161
  48. Lopes, 2009, Measurement, interpretation and use of haemodynamic parameters in pulmonary hypertension associated with congenital cardiac disease, Cardiol Young, 19, 431, 10.1017/S1047951109990771 · doi:10.1017/s1047951109990771
  49. Neutze, 1989, Assessment and follow-up of patients with ventricular septal defect and elevated pulmonary vascular resistance, Am J Cardiol, 63, 327, 10.1016/0002-9149(89)90340-8 · DOI
  50. Steele, 1987, Isolated atrial septal defect with pulmonary vascular obstructive disease–long-term follow-up and prediction of outcome after surgical correction, Circulation, 76, 1037, 10.1161/01.CIR.76.5.1037 · DOI · Paper page
  51. Galie, 2009, A meta-analysis of randomized controlled trials in pulmonary arterial hypertension, Eur Heart J, 30, 394, 10.1093/eurheartj/ehp022 · DOI · Paper page
  52. Lajoie, 2016, Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis, Lancet Respir Med, 4, 291, 10.1016/S2213-2600(16)00027-8 · DOI
  53. Galie, 2015, Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension, N Engl J Med, 373, 834, 10.1056/NEJMoa1413687 · DOI · Paper page
  54. Sitbon, 2015, Selexipag for the treatment of pulmonary arterial hypertension, N Engl J Med, 373, 2522, 10.1056/NEJMoa1503184 · DOI · Paper page
  55. Pulido, 2013, Macitentan and morbidity and mortality in pulmonary arterial hypertension, N Engl J Med, 369, 809, 10.1056/NEJMoa1213917 · DOI · Paper page
  56. Skoro-Sajer, 2018, Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension, Heart, 104, 1195, 10.1136/heartjnl-2017-312143 · doi:10.1136/heartjnl-2017-312143
  57. Galie, 2006, Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study, Circulation, 114, 48, 10.1161/CIRCULATIONAHA.106.630715 · DOI · Paper page
  58. Gatzoulis, 2019, MAESTRO Study Investigators. Evaluation of macitentan in patients with Eisenmenger syndrome, Circulation, 139, 51, 10.1161/CIRCULATIONAHA.118.033575 · DOI
  59. D’Alto, 2012, Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology, Int J Cardiol, 155, 378, 10.1016/j.ijcard.2010.10.051 · DOI
  60. Fuller, 2015, estimating mortality risk for adult congenital heart surgery: an analysis of The Society of Thoracic Surgeons Congenital Heart Surgery Database, Ann Thorac Surg, 100, 1728, 10.1016/j.athoracsur.2015.07.002 · doi:10.1016/j.athoracsur.2015.07.002
  61. O’Brien, 2009, An empirically based tool for analyzing mortality associated with congenital heart surgery, J Thorac Cardiovasc Surg, 138, 1139, 10.1016/j.jtcvs.2009.03.071 · DOI · Paper page
  62. Horer, 2018, Validation of the grown-ups with congenital heart disease score, Heart, 104, 1019, 10.1136/heartjnl-2017-312275 · doi:10.1136/heartjnl-2017-312275
  63. Karamlou, 2008, National practice patterns for management of adult congenital heart disease: operation by pediatric heart surgeons decreases in-hospital death, Circulation, 118, 2345, 10.1161/CIRCULATIONAHA.108.776963 · DOI
  64. Chessa, 2019, ESC Working Group Position Paper: transcatheter adult congenital heart disease interventions: organization of care - recommendations from a Joint Working Group of the European Society of Cardiology (ESC), European Association of Pediatric and Congenital Cardiology (AEPC), and the European Association of Percutaneous Cardiac Intervention (EAPCI), Eur Heart J, 40, 1042, 10.1093/eurheartj/ehy676 · doi:10.1093/eurheartj/ehy676
  65. Haas, 2018, The risk of bacterial endocarditis after percutaneous and surgical biological pulmonary valve implantation, Int J Cardiol, 268, 55, 10.1016/j.ijcard.2018.04.138 · doi:10.1016/j.ijcard.2018.04.138
  66. Kuijpers, 2017, Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: focus on the use of prosthetic material, Eur Heart J, 38, 2048
  67. Ostergaard, 2018, Incidence of infective endocarditis among patients considered at high risk, Eur Heart J, 39, 623, 10.1093/eurheartj/ehx682 · doi:10.1093/eurheartj/ehx682
  68. Thornhill, 2018, Quantifying infective endocarditis risk in patients with predisposing cardiac conditions, Eur Heart J, 39, 586, 10.1093/eurheartj/ehx655 · DOI · Paper page
  69. Pujol, 2016, Usefulness of direct oral anticoagulants in adult congenital heart disease, Am J Cardiol, 117, 450, 10.1016/j.amjcard.2015.10.062 · DOI
  70. Yang, 2019, Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study, Int J Cardiol, 123
  71. Steffel, 2018, The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation, Eur Heart J, 39, 1330, 10.1093/eurheartj/ehy136 · DOI · Paper page
  72. Oechslin, 2004, Hematological management of the cyanotic adult with congenital heart disease, Int J Cardiol, 97, 109, 10.1016/j.ijcard.2004.08.015 · DOI
  73. Oechslin, 2015, Management of adults with cyanotic congenital heart disease, Heart, 101, 485, 10.1136/heartjnl-2012-301685 · DOI
  74. Broberg, 2006, Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease, J Am Coll Cardiol, 48, 356, 10.1016/j.jacc.2006.03.040 · DOI
  75. Oechslin, 2005, Systemic endothelial dysfunction in adults with cyanotic congenital heart disease, Circulation, 112, 1106, 10.1161/CIRCULATIONAHA.105.534073 · DOI
  76. Perloff, 1993, Systemic complications of cyanosis in adults with congenital heart disease. Hematologic derangements, renal function, and urate metabolism, Cardiol Clin, 11, 689
  77. Hjortshoj, 2017, Past and current cause-specific mortality in Eisenmenger syndrome, Eur Heart J, 38, 2060, 10.1093/eurheartj/ehx201 · DOI
  78. Kempny, 2017, Predictors of death in contemporary adult patients with Eisenmenger syndrome: a multicenter study, Circulation, 135, 1432, 10.1161/CIRCULATIONAHA.116.023033 · DOI · Paper page
  79. Sakazaki, 2007, Predictive factors for long-term prognosis in adults with cyanotic congenital heart disease–Japanese multi-center study, Int J Cardiol, 120, 72, 10.1016/j.ijcard.2006.08.081 · DOI
  80. Ammash, 1996, Cerebrovascular events in adult patients with cyanotic congenital heart disease, J Am Coll Cardiol, 28, 768, 10.1016/S0735-1097(96)00196-9 · doi:10.1016/s0735-1097(96)00196-9
  81. Van De Bruaene, 2011, Iron deficiency is associated with adverse outcome in Eisenmenger patients, Eur Heart J, 32, 2790, 10.1093/eurheartj/ehr130 · DOI
  82. Diller, 2012, B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapy, Heart, 98, 736, 10.1136/heartjnl-2011-301522 · DOI
  83. Reardon, 2012, Usefulness of serum brain natriuretic peptide to predict adverse events in patients with the Eisenmenger syndrome, Am J Cardiol, 110, 1523, 10.1016/j.amjcard.2012.06.061 · doi:10.1016/j.amjcard.2012.06.061
  84. Cantor, 1999, Determinants of survival and length of survival in adults with Eisenmenger syndrome, Am J Cardiol, 84, 677, 10.1016/S0002-9149(99)00415-4 · DOI · Paper page
  85. Daliento, 1998, Eisenmenger syndrome. Factors relating to deterioration and death, Eur Heart J, 19, 1845, 10.1053/euhj.1998.1046 · DOI · Paper page
  86. Jensen, 2015, Prevalence of cerebral and pulmonary thrombosis in patients with cyanotic congenital heart disease, Heart, 101, 1540, 10.1136/heartjnl-2015-307657 · DOI
  87. Niwa, 1999, Eisenmenger syndrome in adults: ventricular septal defect, truncus arteriosus, univentricular heart, J Am Coll Cardiol, 34, 223, 10.1016/S0735-1097(99)00153-9 · DOI
  88. Perloff, 2003, Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension, Am J Cardiol, 92, 182, 10.1016/S0002-9149(03)00535-6 · DOI
  89. Silversides, 2003, Pulmonary thrombosis in adults with Eisenmenger syndrome, J Am Coll Cardiol, 42, 1982, 10.1016/j.jacc.2003.07.022 · DOI
  90. Broberg, 2007, Pulmonary arterial thrombosis in Eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity, J Am Coll Cardiol, 50, 634, 10.1016/j.jacc.2007.04.056 · DOI · Paper page
  91. Perloff, 1993, Risk of stroke in adults with cyanotic congenital heart disease, Circulation, 87, 1954, 10.1161/01.CIR.87.6.1954 · DOI · Paper page
  92. Wand, 2018, Inhaled tranexamic acid for hemoptysis treatment: a randomized controlled trial, Chest, 154, 1379, 10.1016/j.chest.2018.09.026 · doi:10.1016/j.chest.2018.09.026
  93. Broberg, 2007, Adult patients with Eisenmenger syndrome report flying safely on commercial airlines, Heart, 93, 1599, 10.1136/hrt.2006.105239 · DOI
  94. Harinck, 1996, Air travel and adults with cyanotic congenital heart disease, Circulation, 93, 272, 10.1161/01.CIR.93.2.272 · DOI
  95. Presbitero, 1994, Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus, Circulation, 89, 2673, 10.1161/01.CIR.89.6.2673 · DOI · Paper page
  96. Engelfriet, 2009, Gender differences in adult congenital heart disease, Neth Heart J, 17, 414, 10.1007/BF03086294 · DOI
  97. Marelli, 2007, Congenital heart disease in the general population: changing prevalence and age distribution, Circulation, 115, 163, 10.1161/CIRCULATIONAHA.106.627224 · DOI · Paper page
  98. Oliver, 2017, Impact of age and sex on survival and causes of death in adults with congenital heart disease, Int J Cardiol, 245, 119, 10.1016/j.ijcard.2017.06.060 · DOI
  99. Zomer, 2013, Sex differences in hospital mortality in adults with congenital heart disease: the impact of reproductive health, J Am Coll Cardiol, 62, 58, 10.1016/j.jacc.2013.03.056 · DOI
  100. Verheugt, 2008, Gender and outcome in adult congenital heart disease, Circulation, 118, 26, 10.1161/CIRCULATIONAHA.107.758086 · DOI
  101. D’Alto, 2019, Does gender affect the prognosis and risk of complications in patients with congenital heart disease in the modern era?, Int J Cardiol, 290, 156, 10.1016/j.ijcard.2019.05.010 · DOI
  102. Meijboom, 2005, Aortic root growth in men and women with the Marfan’s syndrome, Am J Cardiol, 96, 1441, 10.1016/j.amjcard.2005.06.094 · DOI
  103. Sluman, 2014, Congenital heart disease may hurt men more than women in job participation, Int J Cardiol, 172, 230, 10.1016/j.ijcard.2013.12.215 · doi:10.1016/j.ijcard.2013.12.215
  104. Goossens, 2011, SWITCH(2) Investigators. Transfer of adolescents with congenital heart disease from pediatric cardiology to adult health care: an analysis of transfer destinations, J Am Coll Cardiol, 57, 2368, 10.1016/j.jacc.2010.11.068 · DOI
  105. Larsson, 2019, APPROACH-IS Consortium; International Society for Adult Congenital Heart Disease (ISACHD). Geographical variation and predictors of physical activity level in adults with congenital heart disease, Int J Cardiol Heart Vasc, 22, 20
  106. van der Bom, 2015, Contemporary survival of adults with congenital heart disease, Heart, 101, 1989, 10.1136/heartjnl-2015-308144 · DOI
  107. Afilalo, 2011, Geriatric congenital heart disease: burden of disease and predictors of mortality, J Am Coll Cardiol, 58, 1509, 10.1016/j.jacc.2011.06.041 · DOI
  108. Tutarel, 2014, Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality, Eur Heart J, 35, 725, 10.1093/eurheartj/eht257 · DOI · Paper page
  109. Bhatt, 2015, American Heart Association Council on Clinical Cardiology. Congenital heart disease in the older adult: a scientific statement from the American Heart Association, Circulation, 131, 1884, 10.1161/CIR.0000000000000204 · DOI · Paper page
  110. Greutmann, 2013, Facilitators of and barriers to advance care planning in adult congenital heart disease, Congenit Heart Dis, 8, 281, 10.1111/chd.12025 · DOI
  111. Troost, 2019, Advanced care planning in adult congenital heart disease: transitioning from repair to palliation and end-of-life care, Int J Cardiol, 279, 57, 10.1016/j.ijcard.2018.10.078 · DOI
  112. Gibbs, 2002, Living with and dying from heart failure: the role of palliative care, Heart, 88, ii36, 10.1136/heart.88.suppl_2.ii36 · DOI
  113. Crossland, 2004, Life insurance and mortgage application in adults with congenital heart disease, Eur J Cardiothorac Surg, 25, 931, 10.1016/j.ejcts.2004.01.040 · doi:10.1016/j.ejcts.2004.01.040
  114. Pickup, 2016, Travel insurance in adult congenital heart disease - do they declare their condition?, Int J Cardiol, 223, 316, 10.1016/j.ijcard.2016.08.098 · doi:10.1016/j.ijcard.2016.08.098
  115. Sluman, 2015, Uncertainties in insurances for adults with congenital heart disease, Int J Cardiol, 186, 93, 10.1016/j.ijcard.2015.03.208 · doi:10.1016/j.ijcard.2015.03.208
  116. Sluman, 2019, APPROACH-IS consortium tISfACHDI. Education as important predictor for successful employment in adults with congenital heart disease worldwide, Congenit Heart Dis, 14, 362, 10.1111/chd.12747 · DOI
  117. Opic, 2015, Sports participation in adults with congenital heart disease, Int J Cardiol, 187, 175, 10.1016/j.ijcard.2015.03.107 · DOI
  118. Kristensen, 2014, 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA), Eur Heart J, 35, 2383, 10.1093/eurheartj/ehu282 · DOI · Paper page
  119. Stout, 2018, 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease, Circulation
  120. van Hagen, 2016, Global cardiac risk assessment in the Registry Of Pregnancy And Cardiac disease: results of a registry from the European Society of Cardiology, Eur J Heart Fail, 18, 523, 10.1002/ejhf.501 · DOI
  121. Sliwa, 2016, Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology, Eur J Heart Fail, 18, 1119, 10.1002/ejhf.594 · DOI
  122. Roos-Hesselink, 2019, Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac Disease (ROPAC), Eur Heart J, 40, 3848, 10.1093/eurheartj/ehz136 · DOI · Paper page
  123. van Hagen, 2017, Incidence and predictors of obstetric and fetal complications in women with structural heart disease, Heart, 103, 1610, 10.1136/heartjnl-2016-310644 · DOI
  124. Roos-Hesselink, 2015, Contraception and cardiovascular disease, Eur Heart J, 36, 1728, 10.1093/eurheartj/ehv141 · DOI
  125. Humaidan, 2016, Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials, Hum Reprod, 31, 1997, 10.1093/humrep/dew149 · DOI · Paper page
  126. Kametas, 2003, Maternal cardiac function in twin pregnancy, Obstet Gynecol, 102, 806
  127. Opic, 2013, Sexual functioning is impaired in adults with congenital heart disease, Int J Cardiol, 168, 3872, 10.1016/j.ijcard.2013.06.029 · DOI
  128. De Backer, 2019, Genetic counselling and testing in adults with congenital heart disease: a consensus document of the ESC Working Group of Grown-Up Congenital Heart Disease, the ESC Working Group on Aorta and Peripheral Vascular Disease and the European Society of Human Genetics, Eur J Prev Cardiol
  129. Pierpont, 2018, American Heart Association Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Genomic and Precision Medicine. Genetic basis for congenital heart disease: revisited: a scientific statement from the American Heart Association, Circulation, 138, e653, 10.1161/CIR.0000000000000606 · DOI · Paper page
  130. Nyboe, 2018, Long-term mortality in patients with atrial septal defect: a nationwide cohort-study, Eur Heart J, 39, 993, 10.1093/eurheartj/ehx687 · DOI
  131. Gatzoulis, 1999, Atrial arrhythmia after surgical closure of atrial septal defects in adults, N Engl J Med, 340, 839, 10.1056/NEJM199903183401103 · DOI · Paper page
  132. Roos-Hesselink, 2003, Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21-33 years, Eur Heart J, 24, 190, 10.1016/S0195-668X(02)00383-4 · DOI · Paper page
  133. Attie, 2001, Surgical treatment for secundum atrial septal defects in patients >40 years old. A randomized clinical trial, J Am Coll Cardiol, 38, 2035, 10.1016/S0735-1097(01)01635-7 · DOI · Paper page
  134. Oster, 2019, Interventional therapy versus medical therapy for secundum atrial septal defect: a systematic review (part 2) for the 2018 AHA/ACC Guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, Circulation, 139, e814, 10.1161/CIR.0000000000000605 · DOI
  135. Butera, 2006, Percutaneous versus surgical closure of secundum atrial septal defect: comparison of early results and complications, Am Heart J, 151, 228, 10.1016/j.ahj.2005.02.051 · DOI · Paper page
  136. Fischer, 2003, Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients, Heart, 89, 199, 10.1136/heart.89.2.199 · DOI · Paper page
  137. Amin, 2004, Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk, Catheter Cardiovasc Interv, 63, 496
  138. Krumsdorf, 2004, Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients, J Am Coll Cardiol, 43, 302, 10.1016/j.jacc.2003.10.030 · DOI · Paper page
  139. Du, 2002, Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial, J Am Coll Cardiol, 39, 1836, 10.1016/S0735-1097(02)01862-4 · DOI · Paper page
  140. Humenberger, 2011, Benefit of atrial septal defect closure in adults: impact of age, Eur Heart J, 32, 553, 10.1093/eurheartj/ehq352 · DOI · Paper page
  141. Tadros, 2016, Atrial septal defect closure with left ventricular dysfunction, EuroIntervention, 12, X13, 10.4244/EIJV12SXA3 · doi:10.4244/eijv12sxa3
  142. Yong, 2009, Pulmonary arterial hypertension in patients with transcatheter closure of secundum atrial septal defects: a longitudinal study, Circ Cardiovasc Interv, 2, 455, 10.1161/CIRCINTERVENTIONS.108.826560 · DOI
  143. D’Alto, 2013, Hemodynamics of patients developing pulmonary arterial hypertension after shunt closure, Int J Cardiol, 168, 3797, 10.1016/j.ijcard.2013.06.036 · DOI
  144. Lopez, 2018, Classification of ventricular septal defects for the Eleventh Iteration of the International Classification of Diseases-striving for consensus: a report from the International Society for Nomenclature of Paediatric and Congenital Heart Disease, Ann Thorac Surg, 106, 1578, 10.1016/j.athoracsur.2018.06.020 · doi:10.1016/j.athoracsur.2018.06.020
  145. Miyake, 2008, Spontaneous closure of perimembranous ventricular septal defect after school age, Pediatr Int, 50, 632, 10.1111/j.1442-200X.2008.02642.x · DOI
  146. Gabriel, 2002, Long-term outcome of patients with ventricular septal defect considered not to require surgical closure during childhood, J Am Coll Cardiol, 39, 1066, 10.1016/S0735-1097(02)01706-0 · DOI
  147. Neumayer, 1998, Small ventricular septal defects in adults, Eur Heart J, 19, 1573, 10.1053/euhj.1998.1083 · DOI · Paper page
  148. Menting, 2015, The unnatural history of the ventricular septal defect: outcome up to 40 years after surgical closure, J Am Coll Cardiol, 65, 1941, 10.1016/j.jacc.2015.02.055 · DOI
  149. Meijboom, 1994, Long-term follow-up after surgical closure of ventricular septal defect in infancy and childhood, J Am Coll Cardiol, 24, 1358, 10.1016/0735-1097(94)90120-1 · DOI
  150. Kidd, 1993, Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects, Circulation, 87, I38
  151. Gatzoulis, 1999, Surgery for partial atrioventricular septal defect in the adult, Ann Thorac Surg, 67, 504, 10.1016/S0003-4975(98)01137-0 · DOI
  152. El-Najdawi, 2000, Operation for partial atrioventricular septal defect: a forty-year review, J Thorac Cardiovasc Surg, 119, 880, 10.1016/S0022-5223(00)70082-1 · DOI
  153. Malhotra, 2008, Reoperation for left atrioventricular valve regurgitation after atrioventricular septal defect repair, Ann Thorac Surg, 86, 147, 10.1016/j.athoracsur.2008.03.040 · DOI
  154. Drenthen, 2005, Cardiac complications relating to pregnancy and recurrence of disease in the offspring of women with atrioventricular septal defects, Eur Heart J, 26, 2581, 10.1093/eurheartj/ehi439 · DOI
  155. Fisher, 1986, Patent ductus arteriosus in adults–long-term follow-up: nonsurgical versus surgical treatment, J Am Coll Cardiol, 8, 280, 10.1016/S0735-1097(86)80040-7 · DOI
  156. Harrison, 1996, Percutaneous catheter closure of the persistently patent ductus arteriosus in the adult, Am J Cardiol, 77, 1094, 10.1016/S0002-9149(96)00139-7 · DOI
  157. John, 1981, The adult ductus: review of surgical experience with 131 patients, J Thorac Cardiovasc Surg, 82, 314, 10.1016/S0022-5223(19)39375-4 · DOI
  158. Rosenhek, 2000, Predictors of outcome in severe, asymptomatic aortic stenosis, N Engl J Med, 343, 611, 10.1056/NEJM200008313430903 · DOI · Paper page
  159. Tzemos, 2008, Outcomes in adults with bicuspid aortic valves, JAMA, 300, 1317, 10.1001/jama.300.11.1317 · DOI · Paper page
  160. Baumgartner, 2017, Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography, Eur Heart J Cardiovasc Imaging, 18, 254, 10.1093/ehjci/jew335 · DOI · Paper page
  161. Thourani, 2015, Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients, Ann Thorac Surg, 99, 55, 10.1016/j.athoracsur.2014.06.050 · DOI · Paper page
  162. Michelena, 2015, Bicuspid aortic valve aortopathy in adults: incidence, etiology, and clinical significance, Int J Cardiol, 201, 400, 10.1016/j.ijcard.2015.08.106 · DOI
  163. Urban, 2001, Supravalvular aortic stenosis: genetic and molecular dissection of a complex mutation in the elastin gene, Hum Genet, 109, 512, 10.1007/s00439-001-0608-z · DOI
  164. Summers, 1998, Evaluation of the aortic root by MRI: insights from patients with homozygous familial hypercholesterolemia, Circulation, 98, 509, 10.1161/01.CIR.98.6.509 · DOI
  165. Greutmann, 2012, Cardiac outcomes in adults with supravalvar aortic stenosis, Eur Heart J, 33, 2442, 10.1093/eurheartj/ehs206 · DOI
  166. Aboulhosn, 2015, Echocardiographic evaluation of congenital left ventricular outflow obstruction, Echocardiography, 32 Suppl 2, S140
  167. Roemers, 2018, Surgical correction of supravalvar aortic stenosis: 52 years’ experience, World J Pediatr Congenit Heart Surg, 9, 131, 10.1177/2150135117745004 · doi:10.1177/2150135117745004
  168. van der Linde, 2013, Natural history of discrete subaortic stenosisin adults: a multicentre study, Eur Heart J, 34, 1548, 10.1093/eurheartj/ehs421 · DOI
  169. Choudhary, 2015, Late outcomes in adults with coarctation of the aorta, Heart, 101, 1190, 10.1136/heartjnl-2014-307035 · DOI
  170. Padang, 2014, Detection of serious complications by MR imaging in asymptomatic young adults with repaired coarctation of the aorta, Heart Lung Circ, 23, 332, 10.1016/j.hlc.2013.10.055 · doi:10.1016/j.hlc.2013.10.055
  171. Ringel, 2013, Acute outcome of stent therapy for coarctation of the aorta: results of the coarctation of the aorta stent trial, Catheter Cardiovasc Interv, 82, 503
  172. Taggart, 2016, COAST II Investigators. Immediate outcomes of covered stent placement for treatment or prevention of aortic wall injury associated with coarctation of the aorta (COAST II), JACC Cardiovasc Interv, 9, 484, 10.1016/j.jcin.2015.11.038 · DOI
  173. Ungerleider, 2013, Contemporary patterns of surgery and outcomes for aortic coarctation: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database, J Thorac Cardiovasc Surg, 145, 150, 10.1016/j.jtcvs.2012.09.053 · doi:10.1016/j.jtcvs.2012.09.053
  174. Hager, 2007, Coarctation Long-term Assessment (COALA): significance of arterial hypertension in a cohort of 404 patients up to 27 years after surgical repair of isolated coarctation of the aorta, even in the absence of restenosis and prosthetic material, J Thorac Cardiovasc Surg, 134, 738, 10.1016/j.jtcvs.2007.04.027 · DOI · Paper page
  175. Morgan, 2013, Systemic blood pressure after stent management for arch coarctation implications for clinical care, JACC Cardiovasc Interv, 6, 192, 10.1016/j.jcin.2012.10.009 · DOI
  176. Troost, 2009, Behaviour of polyester grafts in adult patients with repaired coarctation of the aorta, Eur Heart J, 30, 1136, 10.1093/eurheartj/ehp054 · doi:10.1093/eurheartj/ehp054
  177. Siegmund, 2017, Pregnancy in women with corrected aortic coarctation: uteroplacental Doppler flow and pregnancy outcome, Int J Cardiol, 249, 145, 10.1016/j.ijcard.2017.09.167 · DOI
  178. Attias, 2009, Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders, Circulation, 120, 2541, 10.1161/CIRCULATIONAHA.109.887042 · DOI · Paper page
  179. Jondeau, 2012, Aortic event rate in the Marfan population: a cohort study, Circulation, 125, 226, 10.1161/CIRCULATIONAHA.111.054676 · DOI · Paper page
  180. Rybczynski, 2011, Predictors of outcome of mitral valve prolapse in patients with the Marfan syndrome, Am J Cardiol, 107, 268, 10.1016/j.amjcard.2010.08.070 · DOI
  181. von Kodolitsch, 2016, The role of the multidisciplinary health care team in the management of patients with Marfan syndrome, J Multidiscip Healthc, 9, 587, 10.2147/JMDH.S93680 · doi:10.2147/jmdh.s93680
  182. Loeys, 2010, The revised Ghent nosology for the Marfan syndrome, J Med Genet, 47, 476, 10.1136/jmg.2009.072785 · DOI · Paper page
  183. Arnaud, 2019, Genetic diversity and pathogenic variants as possible predictors of severity in a French sample of nonsyndromic heritable thoracic aortic aneurysms and dissections (nshTAAD), Genet Med, 21, 2015, 10.1038/s41436-019-0444-y · DOI
  184. Campens, 2014, Reference values for echocardiographic assessment of the diameter of the aortic root and ascending aorta spanning all age categories, Am J Cardiol, 114, 914, 10.1016/j.amjcard.2014.06.024 · DOI
  185. Devereux, 2012, Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons >/=15 years of age, Am J Cardiol, 110, 1189, 10.1016/j.amjcard.2012.05.063 · DOI · Paper page
  186. Franken, 2015, Increased aortic tortuosity indicates a more severe aortic phenotype in adults with Marfan syndrome, Int J Cardiol, 194, 7, 10.1016/j.ijcard.2015.05.072 · DOI
  187. Morris, 2011, Increased vertebral artery tortuosity index is associated with adverse outcomes in children and young adults with connective tissue disorders, Circulation, 124, 388, 10.1161/CIRCULATIONAHA.110.990549 · DOI · Paper page
  188. Shores, 1994, Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan’s syndrome, N Engl J Med, 330, 1335, 10.1056/NEJM199405123301902 · DOI · Paper page
  189. Teixido-Tura, 2018, Losartan versus atenolol for prevention of aortic dilation in patients with Marfan syndrome, J Am Coll Cardiol, 72, 1613, 10.1016/j.jacc.2018.07.052 · DOI
  190. Milleron, 2015, Marfan Sartan: a randomized, double-blind, placebo-controlled trial, Eur Heart J, 36, 2160, 10.1093/eurheartj/ehv151 · DOI · Paper page
  191. Pitcher, 2015, Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: a report from the Marfan Treatment Trialists’ Collaboration, Am Heart J, 169, 605, 10.1016/j.ahj.2015.01.011 · doi:10.1016/j.ahj.2015.01.011
  192. David, 2014, A quarter of a century of experience with aortic valve-sparing operations, J Thorac Cardiovasc Surg, 148, 872, 10.1016/j.jtcvs.2014.04.048 · DOI
  193. Groenink, 2016, How to treat Marfan syndrome: an update, Eur Heart J, 37, 986, 10.1093/eurheartj/ehv589 · doi:10.1093/eurheartj/ehv589
  194. Isselbacher, 2016, International Registry of Aortic Dissection Investigators. Recurrent aortic dissection: observations from the International Registry of Aortic Dissection, Circulation, 134, 1013, 10.1161/CIRCULATIONAHA.115.019359 · DOI
  195. Mimoun, 2011, Dissection in Marfan syndrome: the importance of the descending aorta, Eur Heart J, 32, 443, 10.1093/eurheartj/ehq434 · DOI
  196. Verma, 2014, Aortic dilatation in patients with bicuspid aortic valve, N Engl J Med, 370, 1920, 10.1056/NEJMra1207059 · DOI · Paper page
  197. Michelena, 2008, Natural history of asymptomatic patients with normally functioning or minimally dysfunctional bicuspid aortic valve in the community, Circulation, 117, 2776, 10.1161/CIRCULATIONAHA.107.740878 · DOI · Paper page
  198. Detaint, 2014, Aortic dilatation patterns and rates in adults with bicuspid aortic valves: a comparative study with Marfan syndrome and degenerative aortopathy, Heart, 100, 126, 10.1136/heartjnl-2013-304920 · DOI
  199. Oliver, 2009, Risk of aortic root or ascending aorta complications in patients with bicuspid aortic valve with and without coarctation of the aorta, Am J Cardiol, 104, 1001, 10.1016/j.amjcard.2009.05.045 · DOI
  200. Galian-Gay, 2019, Familial clustering of bicuspid aortic valve and its relationship with aortic dilation in first-degree relatives, Heart, 105, 603

200 of 309 shown

Cited by

See all 2,311

Metadata

Authors
Baumgartner, H., De Backer, J., Babu-Narayan, S. V., Budts, W., Chessa, M., Diller, G.-P., lung, B., Kluin, J., Lang, I. M., Meijboom, F., Moons, P., Mulder, B. J. M., Oechslin, E., Roos-Hesselink, J. W., Schwerzmann, M., Sondergaard, L., Zeppenfeld, K., ESC Scientific Document Group, Ernst, S., Ladouceur, M., Aboyans, V., Alexander, D., Christodorescu, R., Corrado, D., D'Alto, M., de Groot, N., Delgado, V., Di Salvo, G., Dos Subira, L., Eicken, A., Fitzsimons, D., Frogoudaki, A. A., Gatzoulis, M., Heymans, S., Hörer, J., Houyel, L., Jondeau, G., Katus, H. A., Landmesser, U., Lewis, B. S., Lyon, A., Mueller, C. E., Mylotte, D., Petersen, S. E., Petronio, A. S., Roffi, M., Rosenhek, R., Shlyakhto, E., Simpson, I. A., Sousa-Uva, M., Torp-Pedersen, C. T., Touyz, R. M., Van De Bruaene, A., Babu-Narayan, S. V., Budts, W., Chessa, M., Diller, G.-P., Iung, B., Kluin, J., Lang, I. M., Meijboom, F., Moons, P., Mulder, B. J. M., Oechslin, E., Roos-Hesselink, J. W., Schwerzmann, M., Sondergaard, L., Zeppenfeld, K., Hammoudi, N., Grigoryan, S. V., Mair, J., Imanov, G., Chesnov, J., Bondue, A., Nabil, N., Kaneva, A., Brida, M., Hadjisavva, O., Rubackova-Popelova, J., Nielsen, D. G., El Sayed, M. H., Ermel, R., Sinisalo, J., Thambo, J.-B., Bakhutashvili, Z., Walther, C., Giannakoulas, G., Bálint, O. H., Lockhart, C. J., Murrone, A. N., Ahmeti, A., Lunegova, O., Rudzitis, A., Saliba, Z., Gumbiene, L., Wagner, K., Caruana, M., Bulatovic, N., Amri, R., Bouma, B. J., Srbinovska-Kostovska, E., Estensen, M.-E., Tomkiewicz-Pajak, L., Coman, I. M., Moiseeva, O., Zavatta, M., Stojsic-Milosavljevic, A., Simkova, I., Prokselj, K., Gallego, P., Johansson, B., Greutmann, M., Boughzela, E., Sirenko, Y., & Coats, L.
Venue
European Heart Journal
Publisher
Oxford University Press (OUP)
Published
2020-08-29
Volume
42
Issue
6
Pages
563-645
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
DOI
10.1093/eurheartj/ehaa554
OpenAlex
W3082168186
Cited by
2,311
References
18
FWCI
163.88
Type
journal article
Language
en
Open access
bronze
Licence
academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 2020 ESC Guidelines for the management of adult congenital heart disease. https://app.cochat.ai/papers/10.1093/eurheartj/ehaa554
The paper
Baumgartner, H., De Backer, J., Babu-Narayan, S. V., Budts, W., Chessa, M., Diller, G.-P., lung, B., Kluin, J., Lang, I. M., Meijboom, F., Moons, P., Mulder, B. J. M., Oechslin, E., Roos-Hesselink, J. W., Schwerzmann, M., Sondergaard, L., Zeppenfeld, K., ESC Scientific Document Group, Ernst, S., . . . Coats, L. (2021). 2020 ESC Guidelines for the management of adult congenital heart disease. European Heart Journal. https://doi.org/10.1093/eurheartj/ehaa554

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.